These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24147900)

  • 1. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
    Millard M; Gallagher JD; Olenyuk BZ; Neamati N
    J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells.
    Fonseca SB; Pereira MP; Mourtada R; Gronda M; Horton KL; Hurren R; Minden MD; Schimmer AD; Kelley SO
    Chem Biol; 2011 Apr; 18(4):445-53. PubMed ID: 21513881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Mitochondrial Transcription Inhibitors Active in Pancreatic Cancer Cells.
    Chen W; Hu S; Mao S; Xu Y; Guo H; Li H; Paulsen MT; Chen X; Ljungman M; Neamati N
    ChemMedChem; 2020 Nov; 15(21):2029-2039. PubMed ID: 32748543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multi-Mitochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance.
    Peng YB; Zhao ZL; Liu T; Xie GJ; Jin C; Deng TG; Sun Y; Li X; Hu XX; Zhang XB; Ye M; Tan WH
    ChemMedChem; 2017 Feb; 12(3):250-256. PubMed ID: 28098432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preliminary in vitro biological evaluation of 7α-testosterone-chlorambucil hybrid designed for the treatment of prostate cancer.
    Bastien D; Hanna R; Leblanc V; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Jun; 64():442-7. PubMed ID: 23665800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill
    Jiang L; Liu Y; Tumbath S; Boudreau MW; Chatkewitz LE; Wang J; Su X; Zahid KR; Li K; Chen Y; Yang K; Hergenrother PJ; Huang X
    Antioxid Redox Signal; 2024 Jul; 41(1-3):74-92. PubMed ID: 37950707
    [No Abstract]   [Full Text] [Related]  

  • 7. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
    Idowu T; Samadder P; Arthur G; Schweizer F
    Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.
    Hu Q; Gao M; Feng G; Liu B
    Angew Chem Int Ed Engl; 2014 Dec; 53(51):14225-9. PubMed ID: 25318447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted combinational therapy inducing mitochondrial dysfunction.
    Shin WS; Park SK; Verwilst P; Koo S; Lee JH; Chi SG; Kim JS
    Chem Commun (Camb); 2017 Jan; 53(7):1281-1284. PubMed ID: 28067351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism.
    Mourtada R; Fonseca SB; Wisnovsky SP; Pereira MP; Wang X; Hurren R; Parfitt J; Larsen L; Smith RA; Murphy MP; Schimmer AD; Kelley SO
    PLoS One; 2013; 8(4):e60253. PubMed ID: 23585833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modifications of mitochondria-targeted chlorambucil alter cell death mechanism but preserve MDR evasion.
    Jean SR; Pereira MP; Kelley SO
    Mol Pharm; 2014 Aug; 11(8):2675-82. PubMed ID: 24922525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis.
    Kunwar A; Jayakumar S; Srivastava AK; Priyadarsini KI
    Arch Toxicol; 2012 Apr; 86(4):603-14. PubMed ID: 22119759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New derivatives of lupane triterpenoids disturb breast cancer mitochondria and induce cell death.
    Serafim TL; Carvalho FS; Bernardo TC; Pereira GC; Perkins E; Holy J; Krasutsky DA; Kolomitsyna ON; Krasutsky PA; Oliveira PJ
    Bioorg Med Chem; 2014 Nov; 22(21):6270-87. PubMed ID: 25245673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol.
    Dilda PJ; Decollogne S; Weerakoon L; Norris MD; Haber M; Allen JD; Hogg PJ
    J Med Chem; 2009 Oct; 52(20):6209-16. PubMed ID: 19788237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
    Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
    Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
    Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
    J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokinetics and mechanism of action of AKO4: a novel nitrogen mustard targeted to bcr-abl.
    Katsoulas A; Rachid Z; Brahimi F; McNamee J; Jean-Claude BJ
    Leuk Res; 2005 May; 29(5):565-72. PubMed ID: 15755509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.